Analysis of short-term clinical efficacy and immune function changes of advanced non-small cell lung cancer after radiotherapy or chemotherapy under CT-guided 125I seed implantation
CT-guided <sup>125</sup>I particle therapy may be an effective treatment for NSCLC that has progressed following radiotherapy and chemotherapy. Local treatments improve patients' quality of life and reduce tumor burden. CT-guided <sup>125</sup>I radioactive seed implantation may improve the immune status of patients with recurrent or progressive NSCLC after radiotherapy and chemotherapy and may enhance the antitumor immune response.
Authors
- Yuting Yuan (ORCID: https://orcid.org/0000-0001-5431-1478)
- Jun Zhou (ORCID: https://orcid.org/0000-0001-7586-9905)
- Songbai Chen (ORCID: https://orcid.org/0000-0001-5531-9113)
- Chuang Li (ORCID: https://orcid.org/0000-0003-0212-2397)
- Zhe Wang (ORCID: https://orcid.org/0000-0003-2017-1045)
- Ruoyu Wang (ORCID: https://orcid.org/0000-0002-7240-558X)
- Guangsheng Zhao
- Yunfeng Kou
Institutions
- Affiliated Zhongshan Hospital of Dalian University (CN)
Publication Details
- Journal
- Frontiers in Oncology
- Published
- 2025-11-06
- DOI
- https://doi.org/10.3389/fonc.2025.1667205
- Citations
- 1
- Primary Topic
- Effects of Radiation Exposure
- Type
- article
- Field-Weighted Citation Impact
- 1.36